Drug Profile
Recombinant liposomal factor VIIa - Recoly
Alternative Names: LongSeven; NecLip-rFVIIaLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Recoly
- Class Blood coagulation factors; Coagulants; Recombinant proteins; Serine endopeptidases
- Mechanism of Action Factor VIIa stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Haemophilia A
Most Recent Events
- 14 Sep 2015 Discontinued - Phase-I/II for Haemophilia A in Russia (IV)